National Health Investors (NHI) Projected to Announce Earnings on Monday

National Health Investors (NYSE:NHI) is expected to announce its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to announce earnings of $1.18 per share and revenue of $68.53 million for the quarter. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Parties can find conference call details on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 10:00 AM ET.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. National Health Investors’s revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.22 earnings per share. On average, analysts expect National Health Investors to post $4.76 EPS for the current fiscal year and $4.98 EPS for the next fiscal year.

National Health Investors Trading Down 0.0%

Shares of NYSE:NHI opened at $67.02 on Monday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The stock has a market capitalization of $3.29 billion, a price-to-earnings ratio of 19.37, a PEG ratio of 4.27 and a beta of 0.49. National Health Investors has a 1-year low of $63.51 and a 1-year high of $91.38. The company has a 50 day moving average price of $68.10 and a 200 day moving average price of $76.41.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.5%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio (DPR) is 108.67%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on NHI. Weiss Ratings lowered National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, September 25th. Truist Financial decreased their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, September 2nd. Huntington initiated coverage on National Health Investors in a research note on Thursday, September 10th. They set an “outperform” rating and a $79.00 target price on the stock. Wells Fargo & Company dropped their target price on National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. Finally, Zacks Research raised shares of National Health Investors from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. Five analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors has a consensus rating of “Moderate Buy” and an average price target of $81.00.

About National Health Investors

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.

NHI’s portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties.